Gad Berdugo work email
- Valid
- Valid
- Valid
- Valid
- Valid
Gad Berdugo personal email
Entrepreneurial, biotechnology C-level executive, who brings extensive experience in global business and corporate development, strategy, operations, finance, investments, and venture management with leading corporations such as Abbott, Baxter, Lazard and several emerging biotech companies. Leverages exceptional leadership and communication skills to formulate and implement business strategies. Analytical problem solver that builds and develops high-performance teams while collaborating with internal and external stakeholders. Builds on diverse background while serving a key role in helping a company execute the right strategic direction and grow.Expertise: Business and Corporate Development, Venture Management, Strategic Partnerships, M&A, Financing, Nasdaq Listing, Due Diligence, Investments, Leadership and Team Building. Specialties: Biotechnology, Biopharmaceuticals, Cancer Immunotherapy, Precision & Personalized Medicine, Molecular Diagnostics, Gene & Cellular Therapies and Gene Editing.
-
Managing PartnerExplorium Capital LlcMiami, Fl, Us -
Strategy, Business & Corporate Development AdvisorNutcracker Therapeutics Aug 2023 - PresentEmeryville, California, UsNutcracker Therapeutics has developed a next generation mRNA technology platform that encompasses all aspects of mRNA therapeutic development including (1) microfluidic, biochip-based, automated manufacturing system for the synthesis of GMP mRNA drug substance and drug product, (2) mRNA sequence design, (3) design and high-volume screening of complex proteins optimized for encoding in mRNA, and (4) proprietary nanoparticle delivery vehicles -
Member Of The Board Of DirectorsEvexta Bio Aug 2021 - PresentParis, Île-De-France, FrClinical stage precision oncology company developing highly innovative therapeutics. www.evextabio.com I am leading board initiatives related to corporate development, strategy and financing. Member of the Nomination and Compensation Committee. -
Managing PartnerExplorium Capital Llc Aug 2021 - PresentNew York City, Ny, UsStrategic and financial advisory firm focusing exclusively on the global biotechnology sector. www.exploriumcapital.com
-
Advisory Committee MemberIsct, International Society For Cell & Gene Therapy Feb 2023 - PresentVancouver, British Columbia, Ca -
Executive In ResidenceColumbia Technology Ventures Nov 2022 - Dec 2024New York, Ny, UsI have worked with inventors at Columbia University to facilitate the transfer of biotechnology research innovations from the lab to the market, as well as supporting startup efforts. Columbia Technology Ventures, the technology transfer office of Columbia University, manages more than 400 invention disclosures from faculty, 100 license deals and 20+ new startups each year. CTV currently has over 1,500 patent assets available for licensing across research fields such as biopharma, medical devices, software, cleantech, semiconductors, and material science. To learn more about CTV and available inventions, please visit http://www.techventures.columbia.edu/. -
Chief Business OfficerEditas Medicine Jul 2020 - Aug 2021Cambridge, Massachusetts, UsEditas (NASDAQ: EDIT) is a leading clinical stage CRISPR genome editing company, developing in vivo gene editing therapies, ex vivo gene edited autologous cell therapies and ex vivo gene edited, off-the-shelf, allogeneic cell therapies, for people living with serious diseases. I led global corporate and business development, alliance management, and corporate strategy. -
Chief Executive Officer, Co-Founder And Member Of The Board Of DirectorsEpivax Therapeutics, Inc. Jul 2017 - Jun 2020Providence, Rhode Island, UsEpiVax Therapeutics Inc. (formerly EpiVax Oncology Inc.) is developing precision personalized cancer therapeutic vaccines, based on mutanome-directed neoantigens, selected using proprietary and validated in silico predictive algorithms. I co-founded EpiVax Oncology Inc., a spin-off from EpiVax Inc. Built and led a team towards the development of a personalized cancer vaccine. Changed its name to EpiVax Therapeutics in 2020. -
Senior Advisor, Strategy And Corporate Development - Epivax Inc.Epivax Therapeutics, Inc. Sep 2016 - Jul 2017Providence, Rhode Island, UsEpiVax is a leading computational immunology company, dedicated to applying its proprietary tools (in-silico, in-vitro and in-vivo) to re-engineering therapeutic proteins and to designing new vaccines for infectious diseases and cancer.
-
Chief Financial Officer And Executive Vice PresidentImmune Pharmaceuticals Inc. Jan 2015 - Dec 2015Fort Lee, New Jersey, UsImmune Pharmaceuticals Inc. (NASDAQ: IMNP) applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer. -
Managing Director, Head Of The Life Sciences SectorTegris Llc 2012 - Jan 2015New York, UsFinancial advisory boutique focusing on domestic and cross-border mergers and acquisitions and strategic financial advice. Tegris merged with LionTree LLC in 2015. -
Founder And Managing PartnerExplorium Capital Llc 2008 - 2012New York City, Ny, UsInvestments, financial & strategic advisory firm focusing exclusively on the global biotechnology sector.
-
Director, Head Of Global Life Sciences Equity Investment ResearchLazard 2001 - 2008New York, New York, UsLazard, one of the world's preeminent financial advisory and asset management firms. With origins dating back to 1848, the firm provides advice on mergers and acquisitions, strategic matters, restructuring and capital structure, capital raising and corporate finance, as well as asset management services to corporations, partnerships, institutions, governments, and individuals. -
Director, Global Business Development, Bioscience GroupBaxter Healthcare 1994 - 2001Deerfield, Illinois, Us -
Assistant Product Manager, Account ExecutiveAbbott 1990 - 1992Abbott Park, Illinois, Us
Gad Berdugo Skills
Gad Berdugo Education Details
-
Northwestern University - Kellogg School Of ManagementHealthcare Economics -
Hec ParisFinance
-
UclBiochemical Engineering
-
Imperial College LondonBiotechnology
Frequently Asked Questions about Gad Berdugo
What company does Gad Berdugo work for?
Gad Berdugo works for Explorium Capital Llc
What is Gad Berdugo's role at the current company?
Gad Berdugo's current role is Managing Partner.
What is Gad Berdugo's email address?
Gad Berdugo's email address is ga****@****med.com
What schools did Gad Berdugo attend?
Gad Berdugo attended Northwestern University - Kellogg School Of Management, Hec Paris, Ucl, Imperial College London.
What skills is Gad Berdugo known for?
Gad Berdugo has skills like Valuation, Corporate Development, Start Ups, Strategy, Due Diligence, Biotechnology, Investment Banking, Venture Capital, Portfolio Management, Corporate Finance, Equity Research, Financial Modeling.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial